Regdanvimab, CAS 2444308-95-4

Product Description: Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Ryu DK, et al. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2. Biochem Biophys Res Commun. 2021 Nov 12;578:91-96.

CAS Number: 2444308-95-4

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: H2O

Target: Angiotensin-converting Enzyme (ACE);SARS-CoV

• SKU: MEXHY-P99346-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99346-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK